NCT01536158View on ClinicalTrials.gov

Oral Paracetamol Versus Oral Ibuprofen in Management of Patent Ductus Arteriosus in Preterm Infants: A Randomised Controlled Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

December 31, 2012

Conditions
Patent Ductus Arteriosus
Interventions
DRUG

Oral paracetamol

Patients will receive oral paracetamol 15 mg/kg per dose every 6 hours for 3 days.

DRUG

Oral ibuprofen

Patients will receive oral ibuprofen at an initial dose of 10 mg/kg, followed by 5 mg/kg at 24 and 48 h.

Trial Locations (1)

06110

Zekai Tahir Burak Maternity Teaching Hospital, Division of Neonatology, Ankara

All Listed Sponsors
lead

Zekai Tahir Burak Women's Health Research and Education Hospital

OTHER

NCT01536158 - Oral Paracetamol Versus Oral Ibuprofen in Management of Patent Ductus Arteriosus in Preterm Infants: A Randomised Controlled Trial | Biotech Hunter | Biotech Hunter